1Attman PO, Alau Povic P. Lipid abnormalities in chronic renal insufficiency. Kidney Int, 1991, (Suppl)39:S16.
2Kaiske BL, O'Donnell MP, Schmitz PG,et al. Renal injury of diet-induced hypercholesterolemia in rats. Kidney Int, 19937:880.
3Samuelsson O, Aurell M, Knight-Gibson C, et al. Apo B-containing liopoproteins and the progression of renal insufficiency.Neplon, 1993, 63:279.
4Guijarro C, Keane WF. Effects of lipids on the pathogenesis of progressive renal failure.Miner Electrolyte Metab, 1996, 22:147.
5Lain KS, Cheng IK, Janus ED, et al.Cholesterol-lowering therapy may retard the progession of diabetic nephropathy. Diabetologia, 1995, 38:604.
6Shoji T, Nishizawa Y, Toyokawa A, et al.Decreased abluminuria by pravastain in hyperlipidemic diabetics. Nephron, 1991, 59:664.
7Andcrson TJ, Mcrcdith IT, Ycung AC, et al. The effect of cholcstcrol-lowcring and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med,1995, 332:481.
8Glazer AA, Inman SR, Stowe NT, et al.Renal microcirculatory effects of lovastatin in rat model of reduced renal mass. J Urolog,1997, 50:812.
9Stowe NT, Inman SR, Tapolyai M, et al.Lovastatin has direct renal hemodynamic effects in a rodent model. J Urolog, 1996,156:249.
10Hafez KS, Inman SR, Stowe NT. Renal hemodynamic effects of lovastatin in renal ablation mdel.J Urolog, 1996, 48:862.
5Henke C, Marineili W,Jessurun J,et al. Macrophage production of basic fibroblast growth factor in the tibroproliferative disorder of alveolar fibrosis after lung injury. Am J Pathol, 1993, 143:1189-1199.
6Nikolic Paterson DJ, Atkins RC. The role of macrophages in glomerulonephritis. Nephrol Dial Transplant. 2001, 16(Supp15):3-7.
7Gueler F, Rong S, Park JK. Postischemic acute renal failure is reduced by short-term statin treatment in a rat model. J Am Soc Nephrol. 2002,13:2288-2298.
